How is the Use of CYP3A4 Inhibitors Monitored in Cancer Patients?
Monitoring involves regular blood tests to measure drug levels and assess liver function. Physicians also monitor patients for signs of toxicity and adjust drug dosages accordingly. In some cases, therapeutic drug monitoring (TDM) is employed to tailor drug dosing to individual patient needs, ensuring the optimal balance between efficacy and safety.
